BIORETEC OY (F:0TN) — Stock Price
BIORETEC OY (F:0TN) is currently trading at €0.02 EUR, up 17.31% today. Over the past 52 weeks, shares have ranged between €0.01 and €1.84. This page tracks BIORETEC OY's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 0TN company net worth.
BIORETEC OY (0TN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BIORETEC OY's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
BIORETEC OY Income Statement — Revenue, Profit & Earnings by Year
BIORETEC OY's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €3.52 Million | €4.54 Million | €3.91 Million | €2.94 Million | €2.00 Million |
| Cost of Revenue | €1.21 Million | €1.32 Million | €1.18 Million | €806.73K | €627.70K |
| Gross Profit | €2.31 Million | €3.22 Million | €2.73 Million | €2.14 Million | €1.38 Million |
| Research & Development | — | — | — | — | — |
| SG&A | — | — | — | — | €111.19K |
| Total Operating Expenses | €12.21 Million | €8.75 Million | €6.94 Million | €5.23 Million | €4.67 Million |
| Operating Income | €-8.69 Million | €-4.20 Million | €-3.03 Million | €-2.29 Million | €-2.67 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €1.31 Million | €590.05K | €856.51K | €123.62K | €3.35 Million |
| Income Before Tax | €-9.88 Million | €-4.61 Million | €-3.79 Million | €-2.42 Million | €-6.02 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-9.48 Million | €-4.61 Million | €-3.79 Million | €-2.42 Million | €-6.02 Million |
BIORETEC OY Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BIORETEC OY's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €11.68 Million | €11.47 Million | €10.66 Million | €3.49 Million | €8.58 Million |
| Total Current Assets | €9.21 Million | €9.75 Million | €9.38 Million | €2.56 Million | €7.72 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €3.04 Million | €2.45 Million | €3.13 Million | €1.02 Million | €6.46 Million |
| Net Receivables | €667.00K | €1.46 Million | €1.22 Million | €352.68K | €312.99K |
| Inventory | €3.89 Million | €1.51 Million | €842.21K | €776.93K | €640.16K |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | €0.00 | €79.21K | €158.42K |
| Total Liabilities | €1.92 Million | €1.74 Million | €2.43 Million | €1.57 Million | €4.24 Million |
| Total Current Liabilities | €1.78 Million | €1.30 Million | €1.76 Million | €863.71K | €4.22 Million |
| Long-term Debt | €138.00K | €434.27K | €671.16K | €702.77K | €22.15K |
| Net Debt | — | — | — | €505.59K | €1.81 Million |
| Total Stockholder Equity | €9.76 Million | €9.74 Million | €8.23 Million | €1.92 Million | €4.34 Million |
| Retained Earnings | €-29.32 Million | €-19.83 Million | €-15.22 Million | €-11.43 Million | €-9.01 Million |
BIORETEC OY Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BIORETEC OY generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-9.76 Million | €-5.11 Million | €-3.44 Million | €-2.36 Million | €-2.39 Million |
| Capital Expenditures | €583.74K | €728.77K | €161.35K | €260.40K | €393.28K |
| Free Cash Flow | €-10.35 Million | €-5.84 Million | €-3.60 Million | €-2.62 Million | €-2.78 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €210.00K | €148.55K | €200.76K | €179.67K | €169.08K |
| Change in Cash | €-2.16 Million | €-621.07K | €5.69 Million | €-5.40 Million | €4.35 Million |
BIORETEC OY Earnings History — EPS Actual vs. Analyst Estimates
Track BIORETEC OY's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for BIORETEC OY.